BeOne Medicines
ONC
#780
Rank
โ‚ฌ26.88 B
Marketcap
259,11ย โ‚ฌ
Share price
-3.77%
Change (1 day)
28.93%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2026 (TTM): โ‚ฌ0.64 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are โ‚ฌ5.73 Billion. In 2025 the company made an earning of โ‚ฌ0.41 Billion, an increase over its 2024 earnings that were of -โ‚ฌ0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.64 B54.69%
2025 โ‚ฌ0.41 B-186.57%
2024 -โ‚ฌ0.49 Billion-52.95%
2023 -โ‚ฌ1.03 Billion-32.52%
2022 -โ‚ฌ1.53 Billion24.39%
2021 -โ‚ฌ1.23 Billion-13.21%
2020 -โ‚ฌ1.42 Billion72.69%
2019 -โ‚ฌ0.82 Billion36.01%
2018 -โ‚ฌ0.61 Billion616.83%
2017 -โ‚ฌ83.75 Million-15.24%
2016 -โ‚ฌ98.82 Million107.91%
2015 -โ‚ฌ47.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚ฌ0.14 Billion-121.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚ฌ15.45 Million-102.40%๐Ÿ‡บ๐Ÿ‡ธ USA